MIRAGO 50 (Mirabegron (50mg))

Mirago 50 Tablet ER is indicated for the management of symptoms associated with an overactive bladder. This condition may manifest as an increased frequency of urination, a strong and urgent desire to urinate, and a loss of control over urination. The medication works by relaxing the muscles surrounding the bladder, thus enhancing its capacity to retain urine. It is essential to follow your healthcare provider’s instructions regarding the dosage and duration of treatment when taking Mirago 50. The tablet can be ingested with food or on an empty stomach, but it should be swallowed whole without any alteration such as crushing or chewing. It is crucial not to discontinue the medication abruptly without consulting a healthcare professional, as this could exacerbate the underlying symptoms. Completing the prescribed treatment regimen is important to achieve optimal results. Patients should be aware of potential side effects, which may include constipation, headaches, elevated blood pressure, nasal congestion, urinary tract infections, increased heart rate, and joint pain. Should any of these effects be persistent or concerning, it is advisable to seek medical guidance promptly. Before starting treatment, inform your healthcare provider of any other medications being taken to avoid adverse interactions. Additionally, individuals who are pregnant or breastfeeding should disclose this information to their doctor, as special considerations may apply. Those with pre-existing liver or kidney conditions should approach this medication with caution and ensure regular follow-ups as recommended.